CCM
TCRT icon

Cupps Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Cupps Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3
Closed -$5K – 206
2015
Q2 		$5K Buy
+3
New +$4.66K ﹤0.01% 163

Other funds holding TCRT

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cupps Capital Management's TCRT Position: Q3 2015 in Review

Cupps Capital Management sold out of Alaunos Therapeutics (TCRT) in Q3 2015, closing a stake of 3 shares — an estimated $5K sold.

Cupps Capital Management first reported a position in TCRT in Q2 2015 and held it in 1 quarter. The position peaked at $5K in Q2 2015. 138 funds tracked by Wall St. Rank hold TCRT as of Q3 2015.

  • Cupps Capital Management reported no remaining Alaunos Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Cupps Capital Management sold 3 Alaunos Therapeutics shares in Q3 2015, an estimated $5K.
  • Cupps Capital Management first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 1 quarter.
  • Cupps Capital Management's Alaunos Therapeutics position peaked at $5K in Q2 2015.
  • 138 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2015.

Based on Cupps Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.